Other than as provided in 180 NAC 7-026, the licensee must
require an authorized user for the oral administration of sodium iodide I-131
in quantities less than or equal to 1.22 GBq (33 mCi), for which a directive is
required, to be a physician who:
(A)
Is certified by a medical specialty board whose certification process includes
all of the requirements in 180 NAC 7-052(C)(i) and (ii) and whose certification
has been recognized by the Department, an Agreement State or the NRC. The names
of board certifications that have been recognized by an Agreement State or the
NRC are posted on the NRC's Medical Uses Licensee Toolkit website; or
(B) Is an authorized user under 180 NAC
7-051(A), 7-051(B) for uses listed in 180 NAC 7-051(B)(i)(2)(f)(i) or (ii), 180
NAC 7-053, or equivalent NRC or Agreement State requirements; or
(C) The physician has:
(i) Successfully completed 80 hours of
classroom and laboratory training, applicable to the medical use of sodium
iodide I-131 for procedures requiring a written directive. The training must
include:
(1) Radiation physics and
instrumentation;
(2) Radiation
protection;
(3) Mathematics
pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
medical use; and
(5) Radiation
biology;
(ii) Work
experience, under the supervision of an authorized user who meets the
requirements in 180 NAC 7-026, 7-051, 7-052, 7-053, or equivalent NRC or
Agreement State requirements. A supervising authorized user who meets the
requirements in 180 NAC 7-051(B), must have experience in administering dosages
as specified in 180 NAC 7-051(B)(i)(2)(f)(i) or (ii) The work experience must
involve:
(1) Ordering, receiving, and
unpacking radioactive materials safely and performing the related radiation
surveys;
(2) Performing quality
control procedures on instruments used to determine the activity of dosages and
performing check for proper operation of survey meters;
(3) Calculating, measuring, and safely
preparing patient or human research subject dosages;
(4) Using administrative controls to prevent
a misadministration involving the use of radioactive material;
(5) Using procedures to contain spilled
radioactive material safely and using proper decontamination procedures;
and
(6) Administering dosages to
patients or human research subjects, that includes at least three cases
involving the oral administration of less than or equal to 1.22 GBq (33 mCi) of
sodium iodide I-131; and
(iii) Obtained written attestation that the
individual has satisfactorily completed the requirements in 180 NAC 7-052(C)(i)
and (ii), and is able to independently fulfill the radiation safety-related
duties as an authorized user for oral administration of less than or equal to
1.22 gigabecquerels (33 millicuries) of sodium iodide I-131 for medical uses
authorized under 180 NAC 7-048. The attestation must be obtained from either:
(1) A preceptor authorized user who meets the
requirements in 180 NAC 7-026, 7-051, 7-052, 7-053, or equivalent NRC or
Agreement State requirements, and has experience in administering dosages as
specified in 180 NAC 7-051(B)(i)(2)(f)(i) or (i); or
(2) A residency program director who affirms
in writing that the attestation represents the consensus of the residency
program faculty where at least one faculty member is an authorized user who
meets the requirements in 180 NAC 7-026, 7-051, 7-052, 7-053, or equivalent NRC
or Agreement State requirements, has experience in administering dosages as
specified in 180 NAC 7-051(B)(i)(2)(f)(i) or (i), and concurs with the
attestation provided by the residency program director. The residency training
program must be approved by the Residency Review Committee of the Accreditation
Council for Graduate Medical Education or the Royal College of Physicians and
Surgeons of Canada or the Council on Postdoctoral Training of the American
Osteopathic Association and must include training and experience specified in
180 NAC 7-052(C).